FIELD: biotechnology.
SUBSTANCE: conjugate of peptide and polyamino acid, binding a vessel endothelium growth factor, is described. The conjugate has a general structure
,
in which R is C6H11; n and m are integers, the ratio of which is 3/1 or 4/1; R1 is peptide with an amino acid sequence Seq ID NO:4.
EFFECT: invention expands the arsenal of means binding a vessel endothelium growth factor.
1 cl, 11 dwg, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
PEPTIDES BINDING VASCULAR ENDOTHELIUM GROWTH FACTOR | 2019 |
|
RU2739246C1 |
ANTI-VEGF ANTIBODIES AND APPLICATIONS THEREOF | 2010 |
|
RU2567639C2 |
POLYSPECIFIC ANTIBODIES | 2009 |
|
RU2547596C2 |
ANTI-BV8 ANTIBODIES AND USING THEM | 2010 |
|
RU2559542C2 |
MOLECULES WHICH BIND LIGANDS AND USE THEREOF | 2014 |
|
RU2699007C2 |
PLATFORM BASED ON CYSTEINE KNOT SCAFFOLD | 2016 |
|
RU2770384C2 |
ANTIANGIOGENIC COMPOUNDS | 2009 |
|
RU2511420C2 |
STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF | 2016 |
|
RU2648152C2 |
PEPTIDE FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION | 2017 |
|
RU2788083C2 |
IMPROVED METHODS OF TREATING VASCULARISED MALIGNANT TUMORS | 2015 |
|
RU2692248C2 |
Authors
Dates
2022-10-21—Published
2020-11-30—Filed